NASDAQ: SANA Sana Biotechnology, Inc. 8-K

Sana Biotechnology reports Q1 2026 financial results

Filed May 11, 2026 · Period ending May 11, 2026 · ~1 min read

Key Changes

  • medium

    Company issued press release announcing financial results for the quarter ended March 31, 2026. Actual figures are in the attached press release, not in the 8-K body itself.

  • low

    This is a routine quarterly earnings announcement filing. The 8-K references the press release as Exhibit 99.1 but does not contain detailed financial data.

    8-K: Earnings verify on EDGAR →

See the full narrative summary and section-by-section diff — create a free account to read more. Takes 30 seconds.

Partner

Trade SANA commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 8, 2026 3:46 PM